94 participants
A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-02-17
- Start Date:
- 2008-03-31
- Completion:
- 2008-10-31
Conditions
- Post Operative Pain
Interventions
- DRUG